期刊文献+

盐酸法舒地尔对冠状动脉慢血流患者血管内皮功能的影响 被引量:4

Effect of fasudil on the vascular endothelial function in patients with coronary slow flow
原文传递
导出
摘要 目的:探讨盐酸法舒地尔对冠状动脉慢血流( CSF)患者血管内皮功能的影响。方法选择冠状动脉造影结果正常但是存在CSF现象的患者82例,按照随机的原则分为常规治疗组与法舒地尔组,每组各41例。常规治疗组给予拜阿司匹林、硝酸酯类、他汀等常规治疗;法舒地尔组在常规治疗的基础上加用盐酸法舒地尔治疗。观察治疗前、后2周两组之间及组内患者心绞痛疗效、冠状动脉血流速度(TIMI)、肱动脉血流介导内皮依赖性舒张功能(FMD)、血浆一氧化氮(NO)、内皮素1(ET-1)及Rho激酶I( ROCKI)水平的变化。结果法舒地尔组治疗后患者心绞痛疗效总有效率为87.80%,常规治疗组总有效率为65.85%,差异有统计学意义(χ2=68.176,P<0.05)。法舒地尔组治疗后患者TIMI计帧、FMD均显著高于治疗前,差异均有统计学意义( t值分别为4.37、4.43,P均<0.05);法舒地尔组患者治疗后血浆NO水平显著高于治疗前,差异有统计学意义( t=5.63,P<0.01);ROCKI、ET-1均显著低于治疗前,差异均有统计学意义(t 值分别为6.19、5.66,P 均<0.01)。常规治疗组治疗后 NO、ROCKI、ET-1水平及FMD、TIMI计帧与治疗前相比,差异均无统计学意义( P 均<0.05)。法舒地尔组治疗后 NO [(36.17±7.64)μmol/L与(24.99±8.96)μmol/L]水平及FMD[(9.96±1.76)%与(5.86±1.45)%]、TIMI计帧(17.53±5.81与29.71±7.83)均较常规治疗组治疗后显著升高(t 值分别为4.06、4.18、5.41,P 均<0.05),ROCKI[(19.57±1.33)μg/L 与(34.38±1.51)μg/L]、ET-1[(14.36±6.05) ng/L 与(20.95±6.57) ng/L]水平较常规治疗组治疗后显著降低( t值分别为3.87、4.36,P均<0.01)。结论盐酸法舒地尔能够显著改善CSF患者的血管内皮功能。 Objective To investigate the effect of fasudil on vascular endothelial function in patients with coronary slow flow( CSF) . Methods Eighty-two patients with CSF and normal coronary angiography were selected and randomly divided into conventional treatment group and fasudil group, 41 cases in each group. Patients in conventional treatment group were given conventional treatment( aspirin,nitrates and atorvasta-tin) ,while patients in the fasudil group were given fasudil on the basis of conventional treatment. The angina pectoris,TIMI,endothelial-dependent flow-mediated vasodilation( FMD) ,the levels of plasma nitric oxide( NO) , endothelin-1( ET-1) and Rho kinase( ROCKI) of the brachial artery were observed in the two groups before and after two weeks of treatment. Results The total effective rate of fasudil group was 87. 80%,higher than that of conventional treatment group of 65. 85%,the difference was significant(χ2=68. 176,P〈0. 05) . TIMI,FMD im-proved in the fasudil group after treatment compared with before treatment, the difference was significant ( t=4. 37,4. 43;P〈0. 05);plasma NO level increased compared with before treatment(t=5. 63,P〈0. 01),while ROCKI,ET-1 level decreased(t=6. 19,5. 66;P〈0. 01). Plasma NO,ET-1,ROCKI and FMD,TIMI of conven-tional treatment had no significantly changes before and after treatment(P〈0. 05). The post-treatment of NO, FMD,TIMI levels in fasudil group were significantly increased compared with conventional group ( ( 36. 17 ±7. 64) μmol/L vs. (24. 99±8. 96) μmol/L,(9. 96±1. 76)% vs. (5. 86±1. 45)%,17. 53±5. 81 vs. 29. 71 ±7. 83;t=4. 06,4. 18,5. 41;P〈0. 05),while ROCKI,ET-1 levels in fasudil group were significantly decreased compared with conventional group((19. 57±1. 33) μg/L vs. (34. 38±1. 51) μg/L,(14. 36±6. 05) ng/L vs. (20. 95±6. 57) ng/L;t=3. 87,4. 36,P〈0. 01). Conclusion Fasudil can significantly improve the vascular en-dothelial function in patients with CSF.
出处 《中国综合临床》 2016年第10期868-871,共4页 Clinical Medicine of China
基金 济宁市医药卫生科技发展计划项目(2015-57-109)
关键词 冠状动脉慢血流 盐酸法舒地尔 一氧化氮 内皮素1 内皮依赖性舒张功能 Coronary slow flow Fasudil Nitric oxide Endothelin-1 Endothelial-dependentflow-mediated vasodilation
  • 相关文献

参考文献8

二级参考文献29

  • 1马晓海,张兆琪,赵轶柯,李铁铮,柳宏,陈韵岱,晏子旭.冠状动脉血流储备与管腔狭窄关系的MR研究[J].中华放射学杂志,2005,39(6):582-587. 被引量:2
  • 2Tambie AA,Demany MA,Zimmenman HA,et al. Angina pecto-ris and slow flow velocity of dye in coronary arteries: a new an-giographic finding [J], Am Heart J,1972,84(1) :66-71.
  • 3Gibson CM, Cannon CP,Daley WL,et al. TIMI frame count: a quantitative method of assessing coronary artery flow [J]. Circu-lation,1996,93(5> :879-888.
  • 4Cakmak M, Tanriverdi H, Cakmak N, et al. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow [J]. Cardiology,2008,110(1):39-44.
  • 5Erdogan D, Caliskan M, Gulh H, et al. Coronary flow reserve is impaired in patients with slow coronary flow[J]. Atherosclerosis, 2007,191(1):168-174.
  • 6Li JJ, Wu YJ,Qin XW, et al. Should slow coronary flow be considered as a coronary syncope [ J ]. Med Hypotheses,2006,66(6):953-956.
  • 7Beltrame JF,Turner SP, Leslie SL,et al. The angiographic and clinical benefits of mibefradil in the coronary slow phenomenon[J]. J Am Coll Cardiol,2004,44(2) :57-62.
  • 8Somlyo AP,Somlyo AV. Signal transduction by G-proteins,rho-kinase and protein phosphatase to smooth musle and nonmuscle myosin [J]. J Physiol,2010,522(2) : 177-185.
  • 9Danton GH,Dietrich WD. Inflammatory mechanisms after ischemia and stroke [J]. J Neuropathol Exp Neurol,2003,62(2): 127-136.
  • 10Nohria A,Grunert ME,Rikitake Y,et al. Rho kinase inhibition improves endothelial function in human subjects with coronaryartery disease [J]. Circ Res,2006,99( 12) :1 426-1 432.

共引文献12

同被引文献32

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部